FAST NEWS: EUDA Health to merge with developer of cancer, women’s health treatments
The Latest: Singapore-based digital health platform EUDA Health Holdings Ltd. (EUDA.US) said on Thursday it has signed a letter of intent to merge with TheoremRx Inc., a U.S.-based developer of…
I-Mab Shaken by Management Moves, Merger Talk and Delisting Threat
Cancer drug maker has been in a wide range of market-moving headlines lately, though its stock still trades near an all-time low Key Takeaways: I-Mab was placed on a list…
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
U.S. securities regulator singles out company for potential delisting, a week after Hutchmed announced its CEO will step down after almost 22 years Key Takeaways U.S. securities regulator says Hutchmed…
China-U.S. IPO Pipeline Creaks Back to Life With Two New Listing Plans
Drug maker LianBio and hotel operator Atour each aims to raise about $350 million with separate New York listings Key takeaways: Two Chinese companies, drug maker LianBio and hotel operator…
Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.
Profitability is now in focus at online drug company, as it seeks to breathe life into its shares that are down 10% this year Key takeaways: 111’s revenue grew 87%…
Everest Medicines Ties With Tencent to Scale Last Mile to Patient Care
Back-to-back deals with Tencent and Medbanks Health seek to build new distributing partnerships ahead of expected first drug approvals Key points: Everest Medicines could gain valuable distribution channels through its…
Drug Maker I-Mab Wins Plaudits as Analysts Urge Caution on Soaring Stock
Cancer specialist’s shares have nearly doubled in the last six months after it posted its first-ever profit and named two well-connected board members Key points: I-Mab’s shares have nearly doubled…
Recent Articles
RELATED ARTICLES
-
Rebounding Perfect Medical finds beauty safe haven in Hong Kong
1830.HK -
Profits recover at Alibaba Health but prognosis unclear
0241.HK
- Margins ring alarm bells as 160 Health readies IPO
- What Chinese companies can learn from Shein on managing U.S.-China tensions – Part 2
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Hywin seeks new wealth outside sagging property market
HYW.US
- Medical imaging group Rimag sets growth focus with IPO
